Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor

By Becker Richard  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 2, 2011-08 ,pp. : 183-187

Springer Publishing Company

Access to resources Recommend Favorite

Vascular Endothelial Tissue Factor Pathway Inhibitor Kinetics in Culture Following Exposure to DX-9065a—A Selective and Direct Factor Xa Inhibitor

By Becker Richard   Alexander John   Li YouFu   Robertson Thomas   Kunitada Satoshi   Spencer Frederick   Yang Hongqiu   Harrington Robert  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 193-197

Springer Publishing Company

Access to resources Recommend Favorite

Synthetic direct and indirect factor Xa inhibitors

By Samama M.M.  

Thrombosis Research, Vol. 106, Iss. 3, 2002-05 ,pp. : 267-273

Elsevier

Access to resources Recommend Favorite

Pharmacological Characterization of a Novel Factor Xa Inhibitor, FXV673

By Chu V.   Brown K.   Colussi D.   Gao J.   Bostwick J.   Kasiewski C.   Bentley R.   Morgan S.   Guertin K.   Pauls H.W.   Gong Y.   Zulli A.   Perrone M.H.   Dunwiddie C.T.   Leadley R.J.  

Thrombosis Research, Vol. 103, Iss. 4, 2001-08 ,pp. : 309-324

Elsevier

Access to resources Recommend Favorite

In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737

By Chu V.   Brown K.   Colussi D.   Choi Y.-M.   Green D.   Pauls H.W.   Spada A.P.   Perrone M.H.   Leadley R.J.   Dunwiddie C.T.  

Thrombosis Research, Vol. 99, Iss. 1, 2000-07 ,pp. : 71-82

Elsevier

Access to resources Recommend Favorite